Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins

Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins

US Patent 10723706 · Granted Jul 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vesicles comprising a PTEN inhibitor and uses of same2023
Mesenchymal stem cells for the treatment of CNS diseases2021
Mesenchymal cell-derived exosomes to treat neurological disorders2021
PERK inhibitors and uses thereof in treating diseases associated with aggregatio2021
PERK inhibitors and uses thereof in treating diseases associated with aggregatio2021
PERK inhibitors and uses thereof in treating diseases associated with aggregatio2021
PERK inhibitors and uses thereof in treating diseases associated with aggregatio2021
PERK inhibitors and uses thereof in treating diseases associated with aggregatio2021
PERK inhibitors and uses thereof in treating diseases associated with aggregatio2021
Isolated cells and populations comprising same for the treatment of CNS diseases2020
Genetically modified muscle cells which express neurotrophic factors2020
Combination treatment for amyotrophic lateral sclerosis (ALS)2019